Search results
Harrow Inc (HROW) Q1 2024 Earnings Call Transcript Highlights: R
Guru Focus· 2 days agoFor the complete transcript of the earnings call, please refer to the full earnings call transcript. Harrow Inc reported a 33% increase in revenues for the first quarter of 2024 compared to ...
Fact Check Team: Study finds majority of Americans at risk of a heart condition
FOX 11 Green Bay· 2 days agoA new study published in the Journal of the American Medical Association found that a majority of...
HHS Final Section 1557 Nondiscrimination Regulations: Gender-Affirming Care and the Role of Carriers...
The National Law Review· 6 days agoWhether and the extent to which group health plans, their carriers and TPAs may be subject to...
Arcutis Biotherapeutics Inc (ARQT) Q1 2024 Earnings Call Transcript Highlights: Robust Growth ...
GuruFocus.com via Yahoo Finance· 1 day agoFor Medicare Part D, discussions are ongoing, and coverage from some Part D plans is expected in the latter half of 2024, with further ...
Car Insurance Increases Can Hit Seniors Hard
The Post-Journal· 3 days agoQuestion: I just got my car insurance bill, and the price went way up. Answer: I just got my car insurance bill, and it also went up! One difference between Auto Insurance and Health Insurance ...
Arcutis Biotherapeutics Inc (ARQT) Q1 2024 Earnings Call Transcr
Guru Focus· 2 days agoFor the complete transcript of the earnings call, please refer to the full earnings call transcript. Arcutis Biotherapeutics Inc (ARQT, Financial) reported strong revenue growth in Q1 2024, ...
Earnings call: Harrow Inc. reports robust revenue growth in Q1 2024 By Investing.com
Investing.com· 2 days agoHarrow, Inc. (ticker not provided), a prominent player in the ophthalmic pharmaceuticals industry,...
Does Medicare Cover the RSV Vaccine?
US News Health· 2 days agoCDC recommends vaccination for higher-risk populations. Two vaccines – Arexvy and Abrysvo – are currently approved by the FDA for those ages 60 and older and offers protection for two years.
What Medicare beneficiaries need to know about generic medications
Fortune· 2 days agoJust ask Susan Jaquith, a retired teacher in Wilson, N.C., who’d been paying about $2,000 a year for a brand-name blood pressure medication and wanted to switch to a less expensive generic.
Earnings call: Seres Therapeutics reports on Q1 2024 with VOWST updates By Investing.com
Investing.com· 3 days agoSeres Therapeutics (NASDAQ:MCRB), a biotechnology firm focused on microbiome therapeutics, has...
